entertainment -WSS

entertainment

author：hotspot 2025-08-31 13:12:39 - browse：96

Colorful one hundred dollar bills -- health tech coverage from STAT — Adobe

Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Doctors push to include dialysis machines in emergency stockpile

focus

explore

WSS

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Doctors are clamoring for more clarity on Paxlovid prescribing

Focused ultrasound for uterine fibroids: an uphill battle

It was time to plan for my old age. If only I could stop crying

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Latest bird flu infection made farmworker sicker than earlier cases

hotspot

entertainment

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Flash flood warnings continue for parts of Missouri, Illinois

How one medical school became remarkably diverse

Adam's Biotech Scorecard: Do Sarepta's exon

Jerome Adams on the need for new antivirals for Covid

Stigma and the return of syphilis

BioMarin wins approval for gene therapy to treat hemophilia A

Google's generative AI to analyze medical images — and talk to docs

Continuity nursing helped my family in our darkest PICU moments

Health insurers say they are turning to AI to cut costs, improve care

knowledge

Dark money group runs ads on China biotech bill

Addiction doctors spar with methadone clinics over legislation

Restaurant meals are packed with calories, and we still keep eating them

First Opinion Podcast: What happens when kids become caregivers?

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

explore

focus

explore

Wikipedia